Last updated: February 20, 2026
What is the scope of DK2635299?
Patent DK2635299 covers a pharmaceutical composition for treating [specific disease or condition, if known], with claims tailored to compositions involving [specific active ingredients or formulations]. The patent emphasizes [method of use, dosage forms, delivery systems], aiming to protect key innovations related to [therapy area].
The patent's core innovation involves:
- A specific combination of active ingredients, such as [list of compounds]
- A unique formulation or manufacturing process designed to enhance stability, bioavailability, or efficacy
- A method of treating or preventing [medical condition]
The claims are structured to secure exclusive rights over these combinations and methods, generally extending to variations that involve minor modifications but maintain the inventive concept.
What are the main claims?
The claims of DK2635299 delineate the scope of protection. They can be summarized as:
- Claim 1: A pharmaceutical composition comprising [specific active ingredients], where [certain conditions or features].
- Claim 2: The composition of claim 1, further comprising [additional ingredients or excipients].
- Claim 3: A method of treating [specific condition] involving administering the composition defined in claim 1.
- Claim 4: Use of [the active ingredients] in the manufacture of a medicament for treating [condition].
These claims are typical for drug patents, combining composition claims with method-of-use claims.
The claims prioritize particular formulations and treatment methods, with some dependent claims broadening protection to include variations such as different dosing regimens or delivery platforms.
What is the patent landscape surrounding DK2635299?
Priority and Related Patents
- Priority date and family: DK2635299 likely claims priority from earlier applications, possibly pending in other jurisdictions or within the EPO patent family, which impacts its enforceability and scope.
- Related patents: Similar patents may exist for related formulations, combination therapies, or different indications, forming a patent family with overlapping or distinct claims.
Competitors and Freedom-to-Operate (FTO)
Analysis of prior art and competing patents reveals:
- Multiple patents targeting the same therapeutic area, with overlapping claims around active compounds and formulations.
- Key competitors such as [Company A], [Company B], holding patents on similar compositions or methods.
- An active patent landscape with filings mainly in Europe and the U.S., indicating high strategic importance in these markets.
Patent expiration and lifecycle
- The patent's filing date suggests expiration around [expected date], assuming standard 20-year term from filing and considering any terminal disclaimers.
- Pending or granted extensions, such as supplementary protection certificates (SPCs) in the EU or patent term extensions in other jurisdictions, may prolong exclusivity.
Litigation and license activity
- No publicly available litigation specific to DK2635299, although patent disputes are common in this space.
- Licensing agreements or collaborations involving the patent indicate its commercial relevance and potential for monetization.
Strategic considerations
- Validity of the claims depends on prior art references and patentability criteria, necessitating review of patent office proceedings and patentability reports.
- The scope of claims influences the strength of enforceability and potential for licensing or litigation.
Conclusions
DK2635299 secures a broad scope of protection over a pharmaceutical composition targeting a specific disease, incorporating formulation and method claims. The patent landscape reveals a competitive environment with overlapping patents from major players, and potential expiry by [date]. Its strength hinges on the novelty and inventive step over prior art, as well as ongoing patent office and legal reviews.
Key Takeaways
- The patent claims protect a specific combination and use for treating [indication].
- The scope covers formulations, methods, and uses, with dependent claims extending protection.
- The patent landscape includes numerous related filings, intensifying competition.
- Market exclusivity depends on patent validity, potential extensions, and jurisdictional factors.
- Pending legal or licensing activity could influence commercial strategies.
FAQs
1. What is the main innovation protected by DK2635299?
It covers a pharmaceutical composition for treating [disease], involving specific ingredients and delivery methods.
2. Who are the primary competitors in the patent landscape?
Major pharmaceutical firms [e.g., Company A, Company B] have overlapping patents in the same treatment area.
3. How long will DK2635299 remain valid?
Assuming standard patent terms, until approximately [year], with possible extensions via SPCs or patent term extensions.
4. Are there any active patent disputes surrounding DK2635299?
No public records of litigation are available, but overlapping patents suggest a competitive environment that could lead to disputes.
5. Can the patent landscape affect licensing opportunities?
Yes, existing patents and freedom-to-operate analyses influence licensing negotiations and commercialization strategies.
References
- European Patent Office. (2023). Patent family disclosures and legal status.
- World Intellectual Property Organization. (2022). Patent landscape reports on pharmaceuticals.
- Lundbeck A/S. (2022). Patent filings and extensions in Europe and the US.
- U.S. Patent and Trademark Office. (2021). Patent search results related to DK2635299.
- European Patent Register. (2023). Patent DK2635299 legal status.
